BioNTech (BNTX) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for BioNTech, as the data feed reports them.

Analysts' mean target, 20 analysts
$112.08
32.1% above the price

The 20 analysts reported by the data feed have a mean price target for BioNTech of $112.08, 32.1% above the $84.86 price (range $74.47–$143.98). 3.54% of the float was sold short as of Oct 30, 2026. Institutions hold 21.2% of the shares and insiders 57.9%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$112.08+32.1% vs price
Analysts
20
Short interest
3.54%of float, Oct 30, 2026
Short ratio
2.02 days
Institutions
21.2%
Insiders
57.86%
Beta
1.33

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

20 analysts covering BioNTech, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $84.86.

Analysts' price targets for BioNTech
Mean price target$112.0832.1% above the price (+32.1%)
Median price target$108.2827.6% above the price (+27.6%)
Highest target$143.9869.7% above the price (+69.7%)
Lowest target$74.4712.2% below the price (−12.2%)
Analysts with a target20

Ratings this month · 21 analysts

Strong buy 1(5%)Buy 13(62%)Hold 7(33%)
Analysts' ratings of BioNTech this month, by rating
RatingAnalystsShare
Strong buy15%
Buy1362%
Hold733%
Sell00%
Strong sell00%

The feed averages these to 1.71 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “buy”.

Who owns BioNTech

Ownership of BioNTech
Held by institutions21.2%493 institutions; percent of shares outstanding
Held by institutions, of the float50.3%
Held by insiders57.86%percent of shares outstanding
Shares outstanding247.93M
Float106Mshares available to trade
Insiders' net purchases, six months00 purchases (0 shares), 0 sales

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in BioNTech
Shares short2.25Mas of Oct 30, 2026
Percent of float3.54%shares short ÷ float
Percent of shares outstanding0.91%shares short ÷ shares outstanding
Short ratio (days to cover)2.02shares short ÷ average daily volume

BioNTech short interest from FINRA, with its history

Trading figures

Trading figures for BioNTech
Beta1.33movement against the market; 1 moves with it
52-week high$124.00
52-week low$79.52
Average volume, 3 months1.25Mshares a day
Average volume, 10 days988.01Kshares a day

Dates to know

Upcoming and recent dates for BioNTech
Ex-dividend dateJun 2, 2022as the feed lists it
Dividend payment dateJun 17, 2022

Questions and answers

What is the analysts' price target for BioNTech (BNTX)?

As reported by the data feed, the mean price target of the 20 analysts covering BioNTech is $112.08, 32.1% above the latest price of $84.86. The highest target is $143.98 and the lowest $74.47. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate BioNTech stock?

Of the 21 ratings the data feed reports for the current month, 1 are strong buy, 13 buy, 7 hold, 0 sell and 0 strong sell.

How many BioNTech shares are sold short?

As reported by the data feed, 2.25M shares were sold short, 3.54% of the float as of Oct 30, 2026. At the average daily volume that is 2.02 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns BioNTech stock?

As reported by the data feed, institutions hold 21.2% of the shares (493 institutions) and insiders 57.9%. There are 247.93M shares outstanding, of which 106M are in the float.

How much does BioNTech stock move with the market?

Its beta, as reported by the data feed, is 1.33: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $79.52 and $124.00.

Cite this page

Funkfolio, “BioNTech (BNTX) statistics: analyst targets, short interest, ownership”, data as of 17 November 2026. https://funkfolio.com/stock/BNTX/statistics

Underlying data: Yahoo Finance.